Drug Delivery: Latest Advances and Prospects

A special issue of BioChem (ISSN 2673-6411).

Deadline for manuscript submissions: 30 April 2025

Special Issue Editor


E-Mail Website
Guest Editor
School of Engineering and Applied Science, University of Virginia, Charlottesville, VA, USA
Interests: chemical engineering; microfluidics; transport; molecular biology; bioengineering; genomics; modeling; machine learning

Special Issue Information

Dear Colleagues, 

Recent advances in technologies and data analysis have revolutionized our approach to drug delivery, precision medicine, and pharmaceutical research. This Special Issue aims to explore the latest developments in these fields, with a particular focus on how novel drug delivery platforms and modeling techniques are enhancing our understanding of drug efficacy, cellular heterogeneity, and personalized therapeutic strategies.

We invite contributions that showcase innovative applications of technologies in drug delivery systems, novel approaches to data analysis for precision medicine, and the integration of these technologies with emerging fields such as machine learning and artificial intelligence. Of particular interest are studies that demonstrate how these technologies are improving drug discovery processes, enabling more accurate predictions of drug responses, and advancing our ability to develop targeted therapies.We look forward to your contributions to this exciting and rapidly evolving field.

Dr. Xueying Zhao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. BioChem is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery systems
  • precision medicine
  • microfluidics
  • machine learning in drug discovery
  • controlled release
  • cellular heterogeneity
  • personalized therapeutics
  • high-throughput screening
  • biopharmaceuticals
  • drug efficacy prediction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop